rs6614552

Variant summary

Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BA1

The NM_020717.5(SHROOM4):​c.3414A>G​(p.Glu1138Glu) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0131 in 1,112,932 control chromosomes in the GnomAD database, including 1,063 homozygotes. There are 2,868 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★). Synonymous variant affecting the same amino acid position (i.e. E1138dup) has been classified as Likely benign.

Frequency

Genomes: 𝑓 0.064 ( 609 hom., 1315 hem., cov: 19)
Exomes 𝑓: 0.0078 ( 454 hom. 1553 hem. )

Consequence

SHROOM4
NM_020717.5 synonymous

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:5

Conservation

PhyloP100: -1.38

Publications

6 publications found
Variant links:
Genes affected
SHROOM4 (HGNC:29215): (shroom family member 4) This gene encodes a member of the APX/Shroom family, which contain an N-terminal PDZ domain and a C-terminal ASD2 motif. The encoded protein may play a role in cytoskeletal architecture. Mutations in this gene have been linked to the X-linked Stocco dos Santos syndrome characterized by cognitive disabilities. Alternatively spliced transcript variants have been described. [provided by RefSeq, Jul 2017]
SHROOM4 Gene-Disease associations (from GenCC):
  • X-linked intellectual disability, Stocco dos Santos type
    Inheritance: XL Classification: SUPPORTIVE, LIMITED Submitted by: Labcorp Genetics (formerly Invitae), Orphanet
  • complex neurodevelopmental disorder
    Inheritance: XL Classification: LIMITED Submitted by: Ambry Genetics
  • X-linked complex neurodevelopmental disorder
    Inheritance: XL Classification: NO_KNOWN Submitted by: ClinGen

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -21 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-1.09).
BP6
Variant X-50607728-T-C is Benign according to our data. Variant chrX-50607728-T-C is described in ClinVar as Benign. ClinVar VariationId is 95972.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-1.38 with no splicing effect.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.218 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
SHROOM4NM_020717.5 linkc.3414A>G p.Glu1138Glu synonymous_variant Exon 6 of 9 ENST00000376020.9 NP_065768.2 Q9ULL8-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
SHROOM4ENST00000376020.9 linkc.3414A>G p.Glu1138Glu synonymous_variant Exon 6 of 9 2 NM_020717.5 ENSP00000365188.2 Q9ULL8-1
SHROOM4ENST00000289292.11 linkc.3414A>G p.Glu1138Glu synonymous_variant Exon 6 of 10 1 ENSP00000289292.7 Q9ULL8-1
SHROOM4ENST00000460112.3 linkc.3066A>G p.Glu1022Glu synonymous_variant Exon 5 of 8 5 ENSP00000421450.1 Q9ULL8-2

Frequencies

GnomAD3 genomes
AF:
0.0637
AC:
6724
AN:
105625
Hom.:
605
Cov.:
19
show subpopulations
Gnomad AFR
AF:
0.222
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.0262
Gnomad ASJ
AF:
0.0113
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.000884
Gnomad FIN
AF:
0.000184
Gnomad MID
AF:
0.0217
Gnomad NFE
AF:
0.00163
Gnomad OTH
AF:
0.0494
GnomAD2 exomes
AF:
0.0189
AC:
2404
AN:
127114
AF XY:
0.0125
show subpopulations
Gnomad AFR exome
AF:
0.215
Gnomad AMR exome
AF:
0.0121
Gnomad ASJ exome
AF:
0.0129
Gnomad EAS exome
AF:
0.000186
Gnomad FIN exome
AF:
0.000829
Gnomad NFE exome
AF:
0.00152
Gnomad OTH exome
AF:
0.0133
GnomAD4 exome
AF:
0.00777
AC:
7827
AN:
1007271
Hom.:
454
Cov.:
27
AF XY:
0.00514
AC XY:
1553
AN XY:
302339
show subpopulations
African (AFR)
AF:
0.227
AC:
5447
AN:
23974
American (AMR)
AF:
0.0126
AC:
415
AN:
32872
Ashkenazi Jewish (ASJ)
AF:
0.0117
AC:
206
AN:
17629
East Asian (EAS)
AF:
0.000103
AC:
3
AN:
29054
South Asian (SAS)
AF:
0.00120
AC:
55
AN:
45941
European-Finnish (FIN)
AF:
0.000545
AC:
21
AN:
38563
Middle Eastern (MID)
AF:
0.0216
AC:
79
AN:
3663
European-Non Finnish (NFE)
AF:
0.000990
AC:
765
AN:
772932
Other (OTH)
AF:
0.0196
AC:
836
AN:
42643
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.457
Heterozygous variant carriers
0
256
512
767
1023
1279
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
172
344
516
688
860
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0639
AC:
6753
AN:
105661
Hom.:
609
Cov.:
19
AF XY:
0.0458
AC XY:
1315
AN XY:
28733
show subpopulations
African (AFR)
AF:
0.222
AC:
6303
AN:
28364
American (AMR)
AF:
0.0263
AC:
261
AN:
9935
Ashkenazi Jewish (ASJ)
AF:
0.0113
AC:
29
AN:
2565
East Asian (EAS)
AF:
0.00
AC:
0
AN:
3358
South Asian (SAS)
AF:
0.000887
AC:
2
AN:
2256
European-Finnish (FIN)
AF:
0.000184
AC:
1
AN:
5426
Middle Eastern (MID)
AF:
0.0191
AC:
4
AN:
209
European-Non Finnish (NFE)
AF:
0.00163
AC:
84
AN:
51478
Other (OTH)
AF:
0.0488
AC:
69
AN:
1413
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.491
Heterozygous variant carriers
0
200
400
599
799
999
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
64
128
192
256
320
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0367
Hom.:
257

ClinVar

Significance: Benign
Submissions summary: Benign:5
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:3
Jul 12, 2015
Ambry Genetics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -

Oct 11, 2013
Genetic Services Laboratory, University of Chicago
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Sep 25, 2015
Eurofins Ntd Llc (ga)
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

SHROOM4-related disorder Benign:1
Jun 11, 2019
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -

not provided Benign:1
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-1.1
CADD
Benign
0.25
DANN
Benign
0.42
PhyloP100
-1.4
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs6614552; hg19: chrX-50350728; COSMIC: COSV56788368; API